12 Month Price Forecast For BCPC
Distance to BCPC Price Forecasts
BCPC Price Momentum
🤔 Considering Balchem (BCPC)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: January 23, 2025 3:19 AM UTC
BCPC Analyst Ratings & Price Targets
Based on our analysis of 3 Wall Street analysts, BCPC has a consensus that is bullish. The median price target is $190.00, with forecasts ranging from $175.00 to $206.00. Currently, there are 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
With BCPC currently trading at $162.10, the median price forecast suggests a 17.2% upside. The most optimistic forecast comes from at , projecting a 27.1% upside, while at provides the most conservative target, suggesting a 8.0% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
BCPC Analyst Consensus
BCPC Price Target Range
Latest BCPC Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for BCPC.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Nov 4, 2024 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $190.00 |
| Jul 31, 2024 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $185.00 |
| May 6, 2024 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $170.00 |
| Feb 20, 2024 | HC Wainwright & Co. | Buy | Maintains | $0.00 | |
| Oct 30, 2023 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $135.00 |
| Jul 31, 2023 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $165.00 |
| Jun 5, 2023 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $150.00 |
| Feb 27, 2023 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $140.00 |
| Nov 7, 2022 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $152.00 |
| Aug 22, 2022 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $164.00 |
| May 2, 2022 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $152.00 |
| Mar 8, 2022 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $155.00 |
| Feb 22, 2022 | Sidoti & Co. | Buy | Upgrade | $0.00 | |
| Jan 10, 2022 | HC Wainwright & Co. | Buy | Maintains | $170.00 | |
| Nov 29, 2021 | Sidoti & Co. | Neutral | Downgrade | $0.00 | |
| Aug 2, 2021 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Upgrade | $160.00 |
| Aug 2, 2021 | Stephens & Co. | Mark Connelly | Equal-Weight | Downgrade | $145.00 |
| Feb 22, 2021 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $145.00 |
| Feb 22, 2021 | Stephens & Co. | Mark Connelly | Overweight | Upgrade | $140.00 |
| Aug 4, 2020 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $126.00 |
Stocks Similar to Balchem Corp
The following stocks are similar to Balchem based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Balchem Corp (BCPC) Financial Data
Balchem Corp has a market capitalization of $5.71B with a P/E ratio of 47.1x. The company generates $942.38M in trailing twelve-month revenue with a 12.9% profit margin.
Revenue growth is +4.3% quarter-over-quarter, while maintaining an operating margin of +20.2% and return on equity of +11.0%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
Balchem Corp (BCPC) Company Overview
About Balchem Corp
Specialty ingredients for diverse global markets.
The company operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. It makes money by developing and selling specialized ingredients and products across various industries including food, pharmaceuticals, and animal health, utilizing a combination of direct sales and distribution through independent agents.
Balchem Corporation has a diverse product portfolio including food ingredients, animal health supplements, and sterilization products. Founded in 1967 and based in Montvale, New Jersey, it caters to both human and animal nutritional needs, as well as healthcare applications, positioning itself as a key player in multiple growth markets.
Company Information
Sector
Basic Materials
Industry
Specialty Chemicals
Employees
1,300
CEO
Mr. Theodore L. Harris
Country
United States
IPO Year
1986
Website
www.balchem.comBalchem Corp (BCPC) Latest News & Analysis
Balchem Corporation (NASDAQ: BCPC) will present at the CJS Securities New Ideas for the New Year Virtual Conference on January 14, 2025.
Balchem's participation in a prominent virtual conference may boost visibility, attract investor interest, and signal potential growth opportunities in the health and nutrition sectors.
The chemicals industry has seen growth of under 2% annually since late 2022, contrasting with a 24% increase in global indexes, according to a McKinsey & Co. report.
The stagnation in growth for chemicals companies contrasts sharply with global market gains, signaling potential underperformance and investment risks in this sector.
Blachem (BCPC) and Fresnillo PLC (FNLPF) have been evaluated against their sector's performance year-to-date. Specific performance metrics were not provided.
Performance comparisons highlight relative strengths or weaknesses, influencing investor sentiment and potential investment decisions in Blachem and Fresnillo within their sectors.
Blachem (BCPC) is highlighted as a potential option for short-term investors, having passed a trading strategy screen for fundamentally sound stocks.
Blachem (BCPC) shows potential for short-term gains due to its strong fundamentals and positive price trends, making it an attractive option for traders seeking quick returns.
Balchem Corporation Announces Dividend
1 month agoBalchem Corporation declared a dividend of $0.87 per share, payable on January 17, 2025, to shareholders of record as of December 26, 2024.
Balchem's dividend declaration signals financial health and stability, potentially attracting income-focused investors and influencing stock price positively ahead of the payout date.
Blachem (BCPC) is identified as a strong option for short-term investors due to its positive price trend and solid fundamentals, passing a trading strategy screen.
Blachem (BCPC) shows potential for short-term gains, indicating strong fundamentals and positive price momentum, attracting traders seeking quick returns.
Frequently Asked Questions About BCPC Stock
What is Balchem Corp's (BCPC) stock forecast for 2025?
Based on our analysis of 3 Wall Street analysts, Balchem Corp (BCPC) has a median price target of $190.00. The highest price target is $206.00 and the lowest is $175.00.
Is BCPC stock a good investment in 2025?
According to current analyst ratings, BCPC has 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $162.10. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for BCPC stock?
Wall Street analysts predict BCPC stock could reach $190.00 in the next 12 months. This represents a 17.2% increase from the current price of $162.10. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Balchem Corp's business model?
The company operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. It makes money by developing and selling specialized ingredients and products across various industries including food, pharmaceuticals, and animal health, utilizing a combination of direct sales and distribution through independent agents.
What is the highest forecasted price for BCPC Balchem Corp?
The highest price target for BCPC is $206.00 from at , which represents a 27.1% increase from the current price of $162.10.
What is the lowest forecasted price for BCPC Balchem Corp?
The lowest price target for BCPC is $175.00 from at , which represents a 8.0% increase from the current price of $162.10.
What is the overall BCPC consensus from analysts for Balchem Corp?
The overall analyst consensus for BCPC is bullish. Out of 3 Wall Street analysts, 2 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $190.00.
How accurate are BCPC stock price projections?
Stock price projections, including those for Balchem Corp, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
